Sigma Pharmaceuticals, a leading pharmacy wholesaler and distributor in the UK, has once again demonstrated its commitment to supporting the local
community by helping raise over £70,000 for local charitable causes.
As per a statement from Watford-based industry leader, they raised £20,000 for Citizens Advice Watford, their selected charity of the year, during the recent
Sigma annual conference held in Sun City, South Africa.
Additionally, Sigma played a vital part in raising more than £52,000 for 'Team George' at the London Marathon Charity run held on Sunday, 21 April 2024 to
support cancer charities.
Throughout the year, Sigma will continue to partner with Citizens Advice Watford, a local charity that provides frontline service to the community, giving free,
expert and impartial advice and support to 8,000 people a year, many of whom are facing crisis situations.
Applauding the work done by this charity, Dr Bharat Shah CBE, Founder and Managing Director at Sigma, said: "It has been eye-opening to learn about the
life-changing impact the charity has on the lives of so many people.
"We have seen how their expert team works day in and day out to speak up for people who have nowhere else to turn, ensuring they receive the support and
services they're entitled to."
A new report based on research from pharmacists across England by Sanofi, has called for the introduction of a 'national self-care strategy' to relieve the
burden currently faced by health services.
The new report, titled 'Driving a self-care revolution in the UK', explores the views of pharmacists, patients and doctors on self-care and the support needed to
deliver it more effectively. While self-care policy measures are estimated to increase monetary savings for healthcare systems and national economies by 16%, this
report highlights the right tools and resources are not yet in place to enable pharmacists to play a greater role in delivering self-care advice and medicines to
patients.
"As many as 77% of pharmacists said they would support the creation of a National Self-Care Strategy to provide national leadership on improving understanding of
self-care and encourage its use among both patients and clinicians," the report said.
According to the report, currently, 33% of pharmacists working for independent or small pharmacy chains do not have the resources to support patients with self-care,
alongside their other roles. "To tackle this, close to half (45%) of pharmacists believe greater emphasis by primary care practitioners on the benefits of self-care
would leave pharmacists in a better place to support patients. Similarly, 42% believe that training and recruiting more pharmacists would improve their capacity to
deliver self-care advice."
The Equality Act (which replaced the Disability Discrimination Act in 2010) is often cited as a reason for supplying medicines in a compliance aid. This is a complex piece of legislation, but, in essence, provides a statutory duty on businesses to make "reasonable adjustments" in relation to the service that they provide to take into account any relevant disability of a service-users.
This statutory obligation might include the provision of a compliance aid where a patient would be at a "substantial disadvantage" without. However, the need to provide medicines in a compliance aid under the Equality Act needs careful consideration and is a balancing exercise.
The NHS Terms of Service for community pharmacies in England state that medicines should be provided in original packs save in certain circumstances, which include because of patient needs.
There is a clear opportunity for community pharmacists and their teams to lead best practice when it comes to supporting the ongoing health needs of older
people. As the global population continues to age, the demand for specialised healthcare services tailored to the elderly is rapidly increasing. Community
pharmacists, with their accessible locations and frequent interactions with patients, are uniquely positioned to play a pivotal role in addressing this growing need.
The ageing population presents a complex set of health challenges, including multiple chronic conditions, polypharmacy, and increased susceptibility to adverse
drug reactions. Community pharmacists, armed with their extensive knowledge of medications and their effects, can serve as the first line of defence in managing
these issues. By leveraging their expertise, they can implement best practices that not only improve the quality of life for older individuals but also reduce the
burden on the broader healthcare system.
One of the primary areas where community pharmacists can make a significant impact is in medication management. As people age, they often find themselves taking
multiple medications for various conditions. This polypharmacy can lead to dangerous drug interactions, side effects, and compliance issues. Community
pharmacists can lead the way in implementing comprehensive medication reviews, ensuring that each patient's drug regimen is optimised for their specific needs
and minimising potential risks.
In his address to both Houses of Parliament today (17 July), King Charles III highlighted the new government's commitment to enhancing the National Health
Service (NHS), reducing waiting times, focussing on preventive care, and improving mental health services.
Marking the first State Opening of Parliament under the Labour government, the King unveiled a raft of bills and draft bills, including the Mental Health Bill
and the Tobacco and Vapes Bill.
King Charles III said: "My government will improve the National Health Service as a service for all, providing care on the basis of need regardless of the ability
to pay.
"It will seek to reduce the waiting times, focus on prevention and improve mental health provision for young people."
Furthermore, the King stated that mental health would be given the same attention and focus as physical health. He announced the introduction of the Mental Health
Bill, which aims to modernise the Mental Health Act to better meet contemporary needs.
The government on Wednesday (March 2) announced an investment of £260 million to support research, development and manufacturing of new drugs, devices and
diagnostics.
Of the total funding, up to £200m has been allocated for research to better access NHS data through Trusted Research Environments and digital clinical trial services, enabling availability of crucial data with the highest levels of privacy.
This will allow the NHS to deliver new life-saving treatments to patients, tackle health inequalities and improve patient care, a government release stated.
The remaining £60m will support commercial-scale manufacturing investments by companies at the leading-edge of innovation, from cell and gene therapies and earlier
and better diagnostic technologies, to medical devices.
The funding for manufacturing investments will be distributed through the new Life Sciences Innovative Manufacturing Fund (LSIMF), following the success of the earlier Medicines and Diagnostics Manufacturing Transformation Fund.
The Independent Pharmacies Association (IPA), in collaboration with the Association of Optometrists (AOP), the British Dental Association (BDA) and the
NHS Confederation has written to health secretary Wes Streeting, urging him to ensure sustainable investment in primary care to strengthen the NHS and better
serve patients.
In their letter, the group congratulated Streeting on his recent appointment as Secretary of State for Health and Social Care and requested a meeting to provide
their joint constructive input towards improving health outcomes.
They expressed concern that recent administrations have failed to follow through on promises to properly integrate and fund primary care, leading to deteriorating
health outcomes.
"Our collective experience is that our National Health Service (NHS), and health outcomes generally, have suffered at the hands of recent administrations that have
talked much about the importance of properly integrating and funding primary care but not followed through with action," they wrote.
The associations emphasised the need to transition the NHS to a Neighbourhood Health Service, where more care is delivered within local communities to identify
problems earlier.
Nine more new products have been classed as 'Drugs for which Discount is Not Deducted' (DND) from 1 July 2022, announced Department of Health and Social
Care (DHSC).
This takes the total number of products granted DND status over the past 2 years to over 500 following checks made by the Pharmaceutical Services Negotiating
Committee.
The Committee had made an application to DHSC and NHSBSA for the following 9 products to be added to the DND list of Individual items to which the discount
deduction scale will no longer apply from July 2022:
Fludrocortisone 50micrograms/5ml oral suspension (Group)
Lorazepam 1mg/5ml oral suspension (Group)
Lorazepam 500micrograms/5ml oral suspension (Group)
Zopiclone 3.75mg/5ml oral solution (Group)
Zopiclone 7.5mg/5ml oral solution (Group)
GA explore5 oral powder 12.5g sachets
HCU explore5 oral powder 12.5g sachets
MSUD explore5 oral powder 12.5g sachets
TYR explore5 oral powder 12.5g sachets
The DND list is updated monthly by the DHSC and includes grouped and individual items. Individual items are separately listed in Part II of the Drug Tariff.
In a collaborative effort, the National Health Services England (NHSE) is set to deliver the RSV(respiratory syncytial virus) vaccination programme where
pharmacists alongside other healthcare professionals will play a crucial role in administering the vaccine.
The UK Health Security Agency has announced the launch of the new vaccination programme targeting the respiratory syncytial virus (RSV), set to begin on 1 September
2024.
Along with GPs, NHS England (NHSE) will "commission a number of community pharmacies to deliver the programme", ensuring broad accessibility and coverage to protect
two high-risk groups: older adults and pregnant women.
RSV is an RNA virus related to mumps, measles, and human parainfluenza viruses.
It commonly causes coughs and colds in winter, transmitted through droplets and secretions from close contact with infected individuals.
While most RSV infections are mild, infants under six months and the elderly are particularly susceptible to severe diseases like bronchiolitis and pneumonia,
which can lead to hospitalisation.
Health Education England (HEE) has developed funded training offers for community pharmacists, including locums aiming to become independent prescribers.
Almost 3000 independent prescribing training places will be available to pharmacists from March 2023.
This training enables pharmacists to support patients from diagnosis to prescribing, and to provide advice and follow-up - while also helping them to feel confident
and prepared for the new challenges of their role.
Courses will be available between April 2023 and March 2024, with several universities offering multiple dates for cohort intakes. Start dates will depend on the
university provider.
Training will enable the provision of new models of care: supporting patients from diagnosis to prescribing, providing advice and follow-up, and preparing pharmacists
to provide clinical care, as pharmacy services become more widespread within emerging clinical pathways.
Matthew Taylor, Chief Executive of the NHS Confederation, delivered a compelling speech at the NHS ConfedExpo 2024, emphasising the critical need for
investment in community-based care and the revitalisation of primary care services.
In his address, Taylor also criticised the current health policy as "not fit for purpose," calling for radical changes to shift the NHS from a reactive to a
proactive health model.
Addressing delegates at the Manchester event, Taylor highlighted the importance of shifting resources towards prevention and community services.
Underscoring a strategic pivot from reactive to proactive health models, he said:
"We must see action to fulfil the long-held vision of a health service that invests better upstream in prevention, in primary and in community-based care."
Wes Streeting MP has been appointed Secretary of State for Health and Social Care in the new Labour Government.
The Ilford North MP will now take on the critical role of overseeing the National Health Service (NHS) and implementing Labour's ambitious health agenda.
At the core of the Labour Party's healthcare reform manifesto is enhancing accessibility to primary and community healthcare. This involves implementing a
'Community Pharmacist Prescribing Service,' to empower pharmacists with independent prescribing rights where clinically suitable.
This initiative aims to alleviate the strain on GP practices and enhance service accessibility.
Additionally, the manifesto proposes piloting Neighbourhood Health Centres, to integrate various healthcare services -such as family doctors, district nurses,
and mental health specialists under one roof.
A groundbreaking research project has revealed that the public is urging the government to prioritise primary and community care over hospitals.
The study also found a strong public willingness to pay higher taxes to enhance NHS services.
The Health Foundation and Ipsos UK conducted the research, combining nationwide polling with in-depth public deliberative workshops.
These workshops, held in King's Lynn, Leeds, and London, constitute one of the most comprehensive public consultations about the future of the NHS in England.
The study published on 16 May underscores the public's desire for a redistribution of NHS resources. If the NHS budget remains unchanged, 60 per cent of those
polled believe the government should focus on improving access to community-based services like general practice and dentistry.
In continuation of the NHS Covid vaccine programme, Covid jabs for five and six-year olds will be available at the local vaccination centres or community pharmacies outside of school hours.
Following the recent JCVI guidance that recommended all children between 5 and 11 would benefit from a non-urgent offer of the COVID vaccine, the NHS will send
invitations to one million families with five and six-year-olds this week.
"Invitations being sent to families this week will set out how easy and convenient it is to take up the offer of a vaccine as part of the NHS COVID vaccination
programme by booking through the National Booking Service, or visiting their nearest walk-in site," NHS said.
Between April 25 and May 1, there are already more than 33,500 children aged five to 11 booked in for their dose of the life-saving vaccine, with a further 50,000 slots still available.
Dr Nikki Kanani, GP and Deputy Lead for the NHS COVID-19 vaccination programme, said: "It is great to see so many families already booked in for their children to receive their Covid vaccine this week, helping to protect themselves against potential future waves of the virus.
Community pharmacists in England have slammed the government's latest decision to reduce the number of people who get a free winter flu jab in the 2022-23 flu season, as concerns related to Covid-19 still exist.
This follows a letter from the NHS England and NHS Improvement (NHSE&I) to clinicians, which stated that the flu vaccination service in 2022-23 will be offered to
patient groups eligible in line with pre-pandemic recommendations. The eligibility was widened significantly after the pandemic struck in 2020 to help reduce the death toll from the Covid-19.
With the change in place people aged 50-64 and schoolchildren aged 11-15 will not be eligible to receive the free jabs on the NHS next winter, pushing millions of people to pay for their jabs privately.
It further recommended that vaccination for frontline healthcare workers and social care workers should be provided by employers as part of the organisation's policy to prevent the transmission of infection.
Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and recycling initiative. NHS Trusts and
community pharmacies participating in the new scheme will have specialised recycling containers for inhalers installed to simplify public participation, Grundon
said in a statement.
Inhalers alone contribute to 4 per cent of NHS CO2 emissions, with around 73 million dispensed annually. By 2026, the health service aims to achieve a 50 per cent
reduction in carbon emissions from waste management, a target that rises to 80 percent between 2028 and 2032, as outlined in the NHS Clinical Waste Strategy.
"This scheme holds the potential to revolutionise the approach of NHS Trusts towards achieving heightened carbon savings and ultimately, net zero emissions," said
Chris Edwards, Grundon's General Manager - Technical. "Each discarded pressurised Metered Dose Inhaler (pMDI) contains highly polluting hydrofluorocarbon (HFC)
gases - a category of greenhouse gas known to be over a thousand times more detrimental than carbon dioxide in driving climate change."
"This initiative securely captures these gases and repurposes them for application in the refrigeration sector. By also recycling the plastic and aluminium
components of the device, we are making a noteworthy contribution to the circular economy," he added.
Once collected, these will undergo processing at Grundon's specialist recycling facility in Ewelme, Oxfordshire, which is capable of handling more than 200,000
inhalers a day. The company aims to recycle 80 per cent of all prescribed inhalers by 2025, the statement added.
Daily hospital admissions in Britain could soon hit a new high because the Omicron variant of the coronavirus is spreading so fast, piling pressure on a health service struggling with staff sickness, England's chief medical officer said on Thursday (December 16).
Britain recorded on Wednesday its highest number of daily coronavirus cases since the start of the pandemic at 78,610.
Omicron is so transmissible that even if it proves to be milder than other variants, it could still cause a surge in hospital admissions, Chris Whitty told lawmakers.
The record for the number of people admitted to hospital with Covid-19 is 4,583 set in January.
"It is possible, because this is going to be very concentrated over a short period of time, even if it's milder, you could end up with a higher number than that going into hospital on a single day," he said.
A new Attention-Deficit-Hyperactive disorder (ADHD) taskforce has been launched by National Health Services England (NHSE) to counter the challenges faced
by many suffering from the neurodevelopmental condition.
The ADHD taskforce aligns with the NHS Long Term Plan's vision to revolutionise mental health services, with a specific emphasis on bolstering community-based
care and reducing reliance on inpatient services.
The NHS has partnered with the government to tackle the escalating demands including increasing funding, improving system efficiency, altering the service
provision model, and clinical prioritisation by bringing together expertise from across a broad range of sectors, including the NHS, education and justice,
to help provide a joined-up approach in response to concerns around rising demand.
Over the past two decades, there has been a significant expansion in the acknowledgement and successful medical interventions for ADHD, leading to a steady
rise in clinical requests throughout the UK.
Boris Johnson has picked Steve Barclay as the new health secretary following the resignation of Sajid Javid, who stepped down on July 5 after saying he had
lost faith in prime minister's leadership.
Barclay - who had served as chief of staff of the prime minister since February 2022 - was previously a junior health minister in 2018, responsible for NHS workforce
and finance, before serving as Brexit secretary, chief secretary to the Treasury, and chancellor of the duchy.
He is the fourth health secretary after Jeremy Hunt, Matt Hancock and Sajid Javid in the past five years.
In a statement on his appointment, Barclay said it was "an honour" to be take up the position, adding: "Our NHS and social care staff have showed us time and again -
throughout the pandemic and beyond - what it means to work with compassion and dedication to transform lives.
"This government is investing more than ever before in our NHS and care services to beat the Covid-19 backlogs, recruit 50,000 more nurses, reform social care and
ensure patients across the country can access the care they need."
A new legislation has been introduced to allow authorised pharmacists along with other healthcare professionals in Northern Ireland to certify 'fit notes',
health minister Robin Swann has announced.
Pharmacists and some other healthcare professionals in England, Scotland and Wales are already allowed to sign 'fit notes'.
Swann announced that 'fit notes' were also set to go fully digital in the future, meaning they would no longer need to be signed in ink.
He said: "I am delighted to introduce this legislation in Northern Ireland. This change will make it easier for people and employers to get the advice they need so
people can stay in work and will help free up doctors' time.
"Too often we see people being faced with unnecessary challenges to get a fit note. More professionals being able to offer this vital service will speed up the
process and support people to return to or remain in work."